
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
Sigma-Aldrich has reached an acquisition agreement with Cell Marque to further their antibody portfolio.
Sigma-Aldrich announced on Oct. 3, 2014, that it had agreed to acquire
"We expect that Cell Marque's strong in vitro diagnostic antibody product lines and solid relationships with pathologists and companies that provide automated staining instrumentation will broaden the diagnostic health reach of Sigma-Aldrich," Frank Wicks, PhD, president of Sigma-Aldrich's Applied Business Unit, said in a press release.
Source:






